Drugmakers pledge transparency to tackle credibility problem in journals

May 25, 2012

Eight leading pharmaceutical companies have approved 10 recommendations aimed at improving transparency to address what they call a “credibility gap” that faces industry-funded clinical research. (American Medical News)